Trials / Completed
CompletedNCT04517942
Evaluation of Peer-led EVERYbody Project
An Evaluation of the Peer-delivered EVERYbody Project: Eating Disorder Risk Factor Reduction for College Students
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- Western Washington University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The second trial of the EVERYbody Project explored the efficacy of the inclusive body image intervention when delivered by college peer leaders. The peer-facilitated EVERYbody Project was compared to a video and expressive writing comparison intervention through one-month follow-up.
Detailed description
The initial trial of the EVERYbody Project established that professional leaders could deliver a universal, inclusive body image program for college students, with benefit above and beyond a waitlist control condition. The second trial of the EVERYbody Project aimed to further evaluate the intervention using a more disseminable facilitator model: trained college student peer leaders. It also utilized a more rigorous comparison condition, where peer leaders conducted the two-session EVERYbody Project program or a time-matched video and expressive writing intervention. College students within a university in the Pacific Northwest United States were invited to participate in programming (universal intervention target). Quantitative assessment included a comparison of changes in eating disorder risk factor outcomes across randomization conditions at pre- and post-intervention and one-month follow-up. Feasibility and acceptability explored the impact of the peer delivered program within universal college student audiences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | EVERYbody Project | Brief behavioral intervention (4 hours across two meetings) |
| OTHER | Video + Expressive Writing | Brief video-based intervention (4 hours across two meetings) |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-01
- First posted
- 2020-08-19
- Last updated
- 2021-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04517942. Inclusion in this directory is not an endorsement.